211 related articles for article (PubMed ID: 12897562)
1. The effect of nasal polyp epithelial cells on eosinophil activation.
Shin SH; Lee SH; Jeong HS; Kita H
Laryngoscope; 2003 Aug; 113(8):1374-7. PubMed ID: 12897562
[TBL] [Abstract][Full Text] [Related]
2. Protease-dependent activation of nasal polyp epithelial cells by airborne fungi leads to migration of eosinophils and neutrophils.
Shin SH; Lee YH; Jeon CH
Acta Otolaryngol; 2006 Dec; 126(12):1286-94. PubMed ID: 17101590
[TBL] [Abstract][Full Text] [Related]
3. IL-4 and TNF-alpha increased the secretion of eotaxin from cultured fibroblasts of nasal polyps with eosinophil infiltration.
Yoshifuku K; Matsune S; Ohori J; Sagara Y; Fukuiwa T; Kurono Y
Rhinology; 2007 Sep; 45(3):235-41. PubMed ID: 17956026
[TBL] [Abstract][Full Text] [Related]
4. Airway epithelial cells release eosinophil survival-promoting factors (GM-CSF) after stimulation of proteinase-activated receptor 2.
Vliagoftis H; Befus AD; Hollenberg MD; Moqbel R
J Allergy Clin Immunol; 2001 Apr; 107(4):679-85. PubMed ID: 11295658
[TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of eotaxin and RANTES messenger RNA in nasal polyps: association of tissue and nasal eosinophils.
Shin SH; Park JY; Jeon CH; Choi JK; Lee SH
Laryngoscope; 2000 Aug; 110(8):1353-7. PubMed ID: 10942140
[TBL] [Abstract][Full Text] [Related]
6. Effect of desloratadine on epithelial cell granulocyte-macrophage colony-stimulating factor secretion and eosinophil survival.
Mullol J; Roca-Ferrer J; Alobid I; Pujols L; Valero A; Xaubet A; Bernal-Sprekelsen M; Picado C
Clin Exp Allergy; 2006 Jan; 36(1):52-8. PubMed ID: 16393266
[TBL] [Abstract][Full Text] [Related]
7. [The role of chemokines in nasal polyps].
Caversaccio M; Hartnell A; Calnan D; Jose P; Mackay IS; Uguccioni M; Baggiolini M; Williams TJ; Conroy DM
Schweiz Med Wochenschr; 2000; Suppl 125():92S-95S. PubMed ID: 11141953
[TBL] [Abstract][Full Text] [Related]
8. Effect of fexofenadine on eosinophil-induced changes in epithelial permeability and cytokine release from nasal epithelial cells of patients with seasonal allergic rhinitis.
Abdelaziz MM; Devalia JL; Khair OA; Bayram H; Prior AJ; Davies RJ
J Allergy Clin Immunol; 1998 Mar; 101(3):410-20. PubMed ID: 9525460
[TBL] [Abstract][Full Text] [Related]
9. The GM-CSF analogue E21R induces apoptosis of normal and activated eosinophils.
Iversen PO; Robinson D; Ying S; Meng Q; Kay AB; Clark-Lewis I; Lopez AF
Am J Respir Crit Care Med; 1997 Nov; 156(5):1628-32. PubMed ID: 9372686
[TBL] [Abstract][Full Text] [Related]
10. [Eosinophil activation by epithelial cells of the respiratory mucosa. Comparative study of normal mucosa and inflammatory mucosa].
Mullol J; Xaubet A; López E; Roca-Ferrer J; Carrión T; Roselló-Catafau J; Picado C
Med Clin (Barc); 1997 May; 109(1):6-11. PubMed ID: 9303983
[TBL] [Abstract][Full Text] [Related]
11. PAR-2 activation regulates IL-8 and GRO-alpha synthesis by NF-kappaB, but not RANTES, IL-6, eotaxin or TARC expression in nasal epithelium.
Rudack C; Steinhoff M; Mooren F; Buddenkotte J; Becker K; von Eiff C; Sachse F
Clin Exp Allergy; 2007 Jul; 37(7):1009-22. PubMed ID: 17581194
[TBL] [Abstract][Full Text] [Related]
12. Analysis of local cytokine gene expression in patients with allergic rhinitis treated with CO2 laser surgery.
Takeno S; Osada R; Furukido K; Yajin K
Laryngoscope; 2000 Nov; 110(11):1968-74. PubMed ID: 11081620
[TBL] [Abstract][Full Text] [Related]
13. Interferon-gamma enhances human eosinophil effector functions induced by granulocyte-macrophage colony-stimulating factor or interleukin-5.
Yamaguchi T; Kimura H; Kurabayashi M; Kozawa K; Kato M
Immunol Lett; 2008 Jun; 118(1):88-95. PubMed ID: 18440651
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical localization of eotaxin immunoreactivity in nasal polyps.
Seto H; Suzaki H; Shioda S
Acta Otolaryngol Suppl; 2004 Aug; (553):99-104. PubMed ID: 15277046
[TBL] [Abstract][Full Text] [Related]
15. Effects of topical anti-inflammatory drugs on eosinophil survival primed by epithelial cells. Additive effect of glucocorticoids and nedocromil sodium.
Mullol J; López E; Roca-Ferrer J; Xaubet A; Pujols L; Fernàndez-Morata JC; Fabra JM; Picado C
Clin Exp Allergy; 1997 Dec; 27(12):1432-41. PubMed ID: 9433939
[TBL] [Abstract][Full Text] [Related]
16. Eosinophil activation in the tissue: synthetic steroid, budesonide, effectively inhibits the survival of eosinophils isolated from peripheral blood but not nasal polyp tissues.
Nonaka R; Nonaka M; Takanashi S; Jordana M; Dolovich J
J Clin Lab Immunol; 1999; 51(1):39-53. PubMed ID: 11424740
[TBL] [Abstract][Full Text] [Related]
17. Conjunctival fibroblasts enhance the survival and functional activity of peripheral blood eosinophils in vitro.
Solomon A; Shmilowich R; Shasha D; Frucht-Pery J; Pe'er J; Bonini S; Levi-Schaffer F
Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1038-44. PubMed ID: 10752939
[TBL] [Abstract][Full Text] [Related]
18. beta(2)-adrenoceptor agonists inhibit release of eosinophil-activating cytokines from human airway smooth muscle cells.
Hallsworth MP; Twort CH; Lee TH; Hirst SJ
Br J Pharmacol; 2001 Feb; 132(3):729-41. PubMed ID: 11159726
[TBL] [Abstract][Full Text] [Related]
19. CC-chemokine receptor 3: a possible target in treatment of allergy-related corneal ulcer.
Fukagawa K; Okada N; Fujishima H; Nakajima T; Tsubota K; Takano Y; Kawasaki H; Saito H; Hirai K
Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):58-62. PubMed ID: 11773013
[TBL] [Abstract][Full Text] [Related]
20. Eotaxin-1, -2, and -3 immunoreactivity and protein concentration in the nasal polyps of eosinophilic chronic rhinosinusitis patients.
Yao T; Kojima Y; Koyanagi A; Yokoi H; Saito T; Kawano K; Furukawa M; Kusunoki T; Ikeda K
Laryngoscope; 2009 Jun; 119(6):1053-9. PubMed ID: 19296494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
